Granahan Investment Management’s iRadimed IRMD Stock Holding History

Granahan Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.16M	Buy	74,966 +70,066	+1,430%	+$6.38M	0.26%	95
2026 Q1	$472K	Buy	4,900 +8	+0.2%	+$800	0.02%	145
2025 Q4	$476K	Sell	4,892 -1,723	-26%	-$148K	0.02%	152
2025 Q3	$471K	Sell	6,615 -891	-12%	-$59.4K	0.02%	140
2025 Q2	$449K	Sell	7,506 -1,053	-12%	-$57.7K	0.02%	150
2025 Q1	$449K	Sell	8,559 -4,086	-32%	-$230K	0.02%	150
2024 Q4	$695K	Buy	12,645 +2,124	+20%	+$112K	0.03%	165
2024 Q3	$529K	Buy	+10,521	New	+$485K	0.02%	177

Other funds holding IRMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Granahan Investment Management's IRMD Position: Q2 2026 in Review

Granahan Investment Management increased its iRadimed (IRMD) stake by 1,430% in Q2 2026, buying an estimated $6.38M and bringing the position to 74,966 shares worth $7.16M. The position accounts for 0.26% of the portfolio, ranked #95.

Granahan Investment Management first reported a position in IRMD in Q3 2024 and has held it in 8 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

Granahan Investment Management held 74,966 shares of iRadimed worth $7.16M as of Q2 2026.
Granahan Investment Management bought 70,066 iRadimed shares in Q2 2026, an estimated $6.38M.
iRadimed made up 0.26% of Granahan Investment Management's portfolio in Q2 2026, its #95 holding.
Granahan Investment Management first reported a position in iRadimed in Q3 2024 and has held it in 8 quarters since.
214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Granahan Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.